Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 318

1.

[ypT0N0 after neoadjuvant chemotherapy and cystectomy for muscle-invasive bladder cancer: Incidence and prognosis. A review from the Bladder group of the French Committee of Oncology].

Pignot G, Houédé N, Roumiguié M, Audenet F, Brunelle S, Colin P, Compérat E, Larré S, Masson-Lecomte A, Neuzillet Y, Xylinas E, Méjean A, Rouprêt M; les membres du CCAFU Vessie.

Prog Urol. 2018 Sep 8. pii: S1166-7087(18)30181-7. doi: 10.1016/j.purol.2018.07.003. [Epub ahead of print] French.

PMID:
30205925
2.

Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.

Gattolliat CH, Couvé S, Meurice G, Oréar C, Droin N, Chiquet M, Ferlicot S, Verkarre V, Vasiliu V, Molinié V, Méjean A, Dessen P, Giraud S, Bressac-De-Paillerets B, Gardie B, Tean Teh B, Richard S, Gad S.

Int J Oncol. 2018 Oct;53(4):1455-1468. doi: 10.3892/ijo.2018.4490. Epub 2018 Jul 19.

3.

Sunitinib Prior to Planned Nephrectomy in Metastatic Renal Cell Carcinoma: Angiogenesis Biomarkers Predict Clinical Outcome in the Prospective Phase II PREINSUT Trial.

Mauge L, Mejean A, Fournier L, Pereira H, Etienne-Grimaldi MC, Levionnois E, Caty A, Abadie-Lacourtoisie S, Culine S, Le Moulec S, Linassier C, Théodore C, Ravaud A, Albiges L, Grine A, Tartour E, Milano G, Gille AS, Verkarre V, Helley D, Oudard S; PREINSUT study group.

Clin Cancer Res. 2018 Jul 30. doi: 10.1158/1078-0432.CCR-18-1045. [Epub ahead of print]

PMID:
30061359
4.

Secondary bladder exstrophy repair with a bilateral gracilis muscle flap in an adult female patient: Case report of an original procedure.

Schaff JB, Fontaine E, Dariane C, Mejean A, Lantieri L, Hivelin M.

Ann Chir Plast Esthet. 2018 Jul 3. pii: S0294-1260(18)30094-3. doi: 10.1016/j.anplas.2018.06.008. [Epub ahead of print]

PMID:
29980317
5.

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.

Méjean A, Ravaud A, Thezenas S, Colas S, Beauval JB, Bensalah K, Geoffrois L, Thiery-Vuillemin A, Cormier L, Lang H, Guy L, Gravis G, Rolland F, Linassier C, Lechevallier E, Beisland C, Aitchison M, Oudard S, Patard JJ, Theodore C, Chevreau C, Laguerre B, Hubert J, Gross-Goupil M, Bernhard JC, Albiges L, Timsit MO, Lebret T, Escudier B.

N Engl J Med. 2018 Aug 2;379(5):417-427. doi: 10.1056/NEJMoa1803675. Epub 2018 Jun 3.

PMID:
29860937
6.

The Case | A 69-year-old man with bladder carcinoma and renal lesions.

Isnard P, Tran HM, Le Stang MB, Parize P, Méjean A, Joly D, Correas JM, Rabant M, Zaidan M.

Kidney Int. 2018 Jun;93(6):1493-1494. doi: 10.1016/j.kint.2017.12.024. No abstract available.

PMID:
29792277
7.

Slowdown of surface diffusion during early stages of bacterial colonization.

Vourc'h T, Peerhossaini H, Léopoldès J, Méjean A, Chauvat F, Cassier-Chauvat C.

Phys Rev E. 2018 Mar;97(3-1):032407. doi: 10.1103/PhysRevE.97.032407.

PMID:
29776183
8.

Single-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma.

Broncy L, Njima BB, Méjean A, Béroud C, Romdhane KB, Ilie M, Hofman V, Muret J, Hofman P, Bouhamed HC, Paterlini-Bréchot AP.

Oncotarget. 2018 Apr 13;9(28):20058-20074. doi: 10.18632/oncotarget.25102. eCollection 2018 Apr 13.

9.

Contemporary assessment of the correlation between Bosniak classification and histological characteristics of surgically removed atypical renal cysts (UroCCR-12 study).

Nouhaud FX, Bernhard JC, Bigot P, Khene ZE, Audenet F, Lang H, Bergerat S, Fraisse G, Grenier N, Cornelis F, Nedelcu C, Béjar S, Fromont-Hankard G, Allory Y, Lindner V, Verkarre V, Daniel L, Yacoub M, Correas JM, Méjean A, Rioux-Leclercq N, Bensalah K.

World J Urol. 2018 May 5. doi: 10.1007/s00345-018-2307-6. [Epub ahead of print]

PMID:
29730837
10.

Nephron sparing surgery in tumours greater than 7cm.

de Saint Aubert N, Audenet F, Mccaig F, Delavaud C, Verkarre V, Le Guilchet T, Dariane C, Pettenati C, Slaoui H, Mejean A, Timsit MO.

Prog Urol. 2018 May;28(6):336-343. doi: 10.1016/j.purol.2018.03.009. Epub 2018 Apr 23.

PMID:
29699856
11.

[French CCAFU guidelines on prostate cancer: hormono-naive metastatic prostate cancer - update 2017].

Rozet F, Hennequin C, Mongiat-Artus P, Beuzeboc P, Beauval JB, Cormier L, Fromont-Hankard G, Ouzzane A, Ploussard G, Renard-Penna R, Méjean A.

Prog Urol. 2018 May;28(6):303-306. doi: 10.1016/j.purol.2018.03.006. Epub 2018 Apr 19. French. No abstract available.

PMID:
29680190
12.

Characterization of CyrI, the hydroxylase involved in the last step of cylindrospermopsin biosynthesis: Binding studies, site-directed mutagenesis and stereoselectivity.

Mazmouz R, Essadik I, Hamdane D, Méjean A, Ploux O.

Arch Biochem Biophys. 2018 Jun 1;647:1-9. doi: 10.1016/j.abb.2018.04.007. Epub 2018 Apr 11.

PMID:
29653078
13.

[Non-palpable testicular tumors in adults: A management based on imaging? Issue from the French Urologic Association Genital Cancer committee's edit].

Rocher L, Feretti L, Camparo P, Savoie PH, Morel-Journel N, Murez T, Sebe P, Flechon A, Méjean A, Durand X.

Prog Urol. 2018 Jun;28(8-9):407-415. doi: 10.1016/j.purol.2018.03.007. Epub 2018 Apr 9. French.

PMID:
29650457
14.

[Tim-3: a novel biomarker and therapeutic target in oncology].

Granier C, Gey A, Dariane C, Mejean A, Timsit MO, Blanc C, Verkarre V, Radulescu C, Fabre E, Vano Y, Oudard S, Badoual C, Tartour É.

Med Sci (Paris). 2018 Mar;34(3):231-237. doi: 10.1051/medsci/20183403011. Epub 2018 Mar 16. French.

PMID:
29547109
15.

Impact of hospital volume and surgeon volume on robot-assisted partial nephrectomy outcomes: a multicentre study.

Peyronnet B, Tondut L, Bernhard JC, Vaessen C, Doumerc N, Sebe P, Pradere B, Guillonneau B, Khene ZE, Nouhaud FX, Brichart N, Seisen T, Alimi Q, Beauval JB, Mathieu R, Rammal A, de la Taille A, Baumert H, Droupy S, Bruyere F, Rouprêt M, Mejean A, Bensalah K; members of the French Committee of Urologic Oncology (CCAFU).

BJU Int. 2018 Jun;121(6):916-922. doi: 10.1111/bju.14175. Epub 2018 Mar 25.

PMID:
29504226
16.

Polymorphisms in the Von Hippel-Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase Inhibitors.

Verbiest A, Lambrechts D, Van Brussel T, Couchy G, Wozniak A, Méjean A, Lerut E, Oudard S, Verkarre V, Job S, de Reynies A, Machiels JP, Patard JJ, Zucman-Rossi J, Beuselinck B.

Clin Genitourin Cancer. 2018 Aug;16(4):266-273. doi: 10.1016/j.clgc.2018.01.013. Epub 2018 Feb 5.

PMID:
29503246
17.

Simple and complex renal cysts in adults: Classification system for renal cystic masses.

Hélénon O, Crosnier A, Verkarre V, Merran S, Méjean A, Correas JM.

Diagn Interv Imaging. 2018 Apr;99(4):189-218. doi: 10.1016/j.diii.2017.10.005. Epub 2018 Feb 23.

PMID:
29482969
18.

[Comparison of operative and oncologic results between partial nephrectomy and radiofrequency ablation for treatment of renal tumors in patients older than 75].

Cholley I, Correas JM, Masson-Lecomte A, Sanchez S, Champy C, Le Guilchet T, Ariane M, Hurel S, Audenet F, Thiounn N, Fontaine E, Mejean A, Timsit MO.

Prog Urol. 2018 Jan;28(1):55-61. doi: 10.1016/j.purol.2017.10.006. Epub 2017 Nov 22. French.

PMID:
29174691
19.

[Sporadic kidney cancer of young subjects: Study of the clinical and pathological features of a bicentric cohort].

Cohen J, Timsit MO, Zerbib OD, Rouprêt M, Verkarre V, Comperat E, Mejean A, Bitker MO.

Prog Urol. 2018 Feb;28(2):94-106. doi: 10.1016/j.purol.2017.10.007. Epub 2017 Nov 21. French.

PMID:
29170016
20.

[Retrospective comparison of the reproducibility and the performances of R.E.N.A.L. score, 12 segments score and UPRCC score for the partial nephrectomy].

Gury-Coupier L, Audenet F, Delavaud C, Timsit MO, Mejean A.

Prog Urol. 2017 Dec;27(16):1050-1057. doi: 10.1016/j.purol.2017.09.007. Epub 2017 Oct 31. French.

PMID:
29097040
21.

Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinoma.

Beuselinck B, Verbiest A, Couchy G, Job S, de Reynies A, Meiller C, Albersen M, Verkarre V, Lerut E, Méjean A, Patard JJ, Laguerre B, Rioux-Leclercq N, Schöffski P, Oudard S, Zucman-Rossi J.

Acta Oncol. 2018 Apr;57(4):498-508. doi: 10.1080/0284186X.2017.1388927. Epub 2017 Nov 2.

PMID:
29095068
22.

Pathological heterogeneity in sporadic synchronous renal tumors: Is the histological concordance predictable?

Beaugerie A, Audenet F, Verkarre V, Delavaud C, Le Guilchet T, Hurel S, de Saint Aubert N, Correas JM, Fontaine E, Richard S, Méjean A, Timsit MO.

Urol Oncol. 2018 Jan;36(1):11.e7-11.e12. doi: 10.1016/j.urolonc.2017.09.002. Epub 2017 Oct 6.

PMID:
28993058
23.

Midterm Outcomes of 12 Renal Transplant Recipients Treated With Eculizumab to Prevent Atypical Hemolytic Syndrome Recurrence.

Levi C, Frémeaux-Bacchi V, Zuber J, Rabant M, Devriese M, Snanoudj R, Scemla A, Amrouche L, Mejean A, Legendre C, Sberro-Soussan R.

Transplantation. 2017 Dec;101(12):2924-2930. doi: 10.1097/TP.0000000000001909.

PMID:
28858176
24.

[Advancement in the treatment of renal carcinoma].

Méjean A.

Nephrol Ther. 2017 May;13(3):154-159. doi: 10.1016/j.nephro.2017.02.008. French.

PMID:
28527565
25.

Biphasic Squamoid Alveolar Renal Cell Carcinoma: 2 Cases in a Family Supporting a Continuous Spectrum With Papillary Type I Renal Cell Carcinoma.

Chartier S, Méjean A, Richard S, Thiounn N, Vasiliu V, Verkarre V.

Am J Surg Pathol. 2017 Jul;41(7):1011-1012. doi: 10.1097/PAS.0000000000000870. No abstract available.

PMID:
28498286
26.

Prospective assessment and histological analysis of adherent perinephric fat in partial nephrectomies.

Dariane C, Le Guilchet T, Hurel S, Audenet F, Beaugerie A, Badoual C, Tordjman J, Clément K, Urien S, Pietak M, Fontaine E, Méjean A, Timsit MO.

Urol Oncol. 2017 Feb;35(2):39.e9-39.e17. doi: 10.1016/j.urolonc.2016.09.008. Epub 2016 Oct 27.

PMID:
28341496
27.

Ablative Therapies for Renal Tumors: Patient Selection, Treatment Planning, and Follow-Up.

Correas JM, Delavaud C, Gregory J, Le Guilchet T, Lamhaut L, Timsit MO, Méjean A, Hélénon O.

Semin Ultrasound CT MR. 2017 Feb;38(1):78-95. doi: 10.1053/j.sult.2016.11.009. Epub 2016 Dec 1. Review.

PMID:
28237283
28.

What is the significance of end-stage renal disease risk estimation in living kidney donors?

Gaillard F, Baron S, Timsit MO, Eladari D, Fournier C, Prot-Bertoye C, Bertocchio JP, Lamhaut L, Friedlander G, Méjean A, Legendre C, Courbebaisse M.

Transpl Int. 2017 Aug;30(8):799-806. doi: 10.1111/tri.12931. Epub 2017 Mar 5.

29.

Immunothérapie dans les cancers de la prostate.

Oudard S, Thibault C, Angelergues A, Tartour E, Timsit MO, Mejean A, Michel C, Vano Y.

Bull Cancer. 2016 Nov;103 Suppl 1:S144-S150. doi: 10.1016/S0007-4551(16)30372-1. French.

PMID:
28057178
30.

Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy.

Beauval JB, Ploussard G, Cabarrou B, Roumiguié M, Ouzzane A, Gas J, Goujon A, Marcq G, Mathieu R, Vincendeau S, Cathelineau X, Mongiat-Artus P, Salomon L, Soulié M, Méjean A, de La Taille A, Rouprêt M, Rozet F; Committee of Cancerology of the Association of French Urology.

World J Urol. 2017 Aug;35(8):1191-1197. doi: 10.1007/s00345-016-1979-z. Epub 2016 Dec 16.

PMID:
27987030
31.

Sunitinib in kidney cancer: 10 years of experience and development.

Nassif E, Thibault C, Vano Y, Fournier L, Mauge L, Verkarre V, Timsit MO, Mejean A, Tartour E, Oudard S.

Expert Rev Anticancer Ther. 2017 Feb;17(2):129-142. doi: 10.1080/14737140.2017.1272415. Epub 2016 Dec 27. Review.

PMID:
27967249
32.

Vitamin D3 Prevents Calcium-Induced Progression of Early-Stage Prostate Tumors by Counteracting TRPC6 and Calcium Sensing Receptor Upregulation.

Bernichtein S, Pigat N, Barry Delongchamps N, Boutillon F, Verkarre V, Camparo P, Reyes-Gomez E, Méjean A, Oudard SM, Lepicard EM, Viltard M, Souberbielle JC, Friedlander G, Capiod T, Goffin V.

Cancer Res. 2017 Jan 15;77(2):355-365. doi: 10.1158/0008-5472.CAN-16-0687. Epub 2016 Nov 22.

33.

Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+ T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma.

Granier C, Dariane C, Combe P, Verkarre V, Urien S, Badoual C, Roussel H, Mandavit M, Ravel P, Sibony M, Biard L, Radulescu C, Vinatier E, Benhamouda N, Peyromaure M, Oudard S, Méjean A, Timsit MO, Gey A, Tartour E.

Cancer Res. 2017 Mar 1;77(5):1075-1082. doi: 10.1158/0008-5472.CAN-16-0274. Epub 2016 Nov 21.

34.

Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.

Dusaud M, Malavaud B, Bayoud Y, Sebe P, Hoepffner JL, Salomon L, Houlgatte A, Pignot G, Rigaud J, Fléchon A, Pfister C, Rouprêt M, Soulié M, Méjean A, Durand X.

J Surg Oncol. 2016 Dec;114(8):992-996. doi: 10.1002/jso.24464. Epub 2016 Nov 18.

PMID:
27859263
35.

Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group.

Oudard S, Elaidi R, Brizard M, Le Rest C, Caillet V, Deveaux S, Benoit G, Corréas JM, Benoudiba F, David P, Gaudric A, Hammel P, Joly D, Timsit MO, Méjean A, Richard S.

Oncotarget. 2016 Dec 20;7(51):85306-85317. doi: 10.18632/oncotarget.13301.

36.

[CCAFU french national guidelines 2016-2018 on prostate cancer].

Rozet F, Hennequin C, Beauval JB, Beuzeboc P, Cormier L, Fromont G, Mongiat-Artus P, Ouzzane A, Ploussard G, Azria D, Brenot-Rossi I, Cancel-Tassin G, Cussenot O, Lebret T, Rebillard X, Soulié M, Renard-Penna R, Méjean A.

Prog Urol. 2016 Nov;27 Suppl 1:S95-S143. doi: 10.1016/S1166-7087(16)30705-9. Review. French.

PMID:
27846936
37.

[CCAFU french national guidelines 2016-2018 on bladder cancer].

Rouprêt M, Neuzillet Y, Masson-Lecomte A, Colin P, Compérat E, Dubosq F, Houédé N, Larré S, Pignot G, Puech P, Roumiguié M, Xylinas E, Méjean A.

Prog Urol. 2016 Nov;27 Suppl 1:S67-S91. doi: 10.1016/S1166-7087(16)30704-7. Review. French.

PMID:
27846935
38.

[CCAFU french national guidelines 2016-2018 on upper tract tumors].

Rouprêt M, Colin P, Xylinas E, Compérat E, Dubosq F, Houédé N, Larré S, Masson-Lecomte A, Neuzillet Y, Pignot G, Puech P, Roumiguié M, Méjean A.

Prog Urol. 2016 Nov;27 Suppl 1:S55-S66. doi: 10.1016/S1166-7087(16)30703-5. Review. French.

PMID:
27846934
39.

[CCAFU french national guidelines 2016-2018 on renal cancer].

Bensalah K, Albiges L, Bernhard JC, Bigot P, Bodin T, Boissier R, Corréas JM, Gimel P, Long JA, Nouhaud FX, Ouzaïd I, Paparel P, Rioux-Leclercq N, Méjean A.

Prog Urol. 2016 Nov;27 Suppl 1:S27-S51. doi: 10.1016/S1166-7087(16)30702-3. French.

PMID:
27846932
40.

[CCAFU french national guidelines 2016-2018 on retroperitoneal sarcoma].

Murez T, Fléchon A, Rocher L, Camparo P, Morel-Journel N, Savoie PH, Ferretti L, Sèbe P, Méjean A, Durand X.

Prog Urol. 2016 Nov;27 Suppl 1:S183-S190. doi: 10.1016/S1166-7087(16)30708-4. Review. French.

PMID:
27846931
41.

[CCAFU french national guidelines 2016-2018 on penile cancer].

Sèbe P, Ferretti L, Savoie PH, Morel-Journel N, Fléchon A, Murez T, Rocher L, Camparo P, Méjean A, Durand X.

Prog Urol. 2016 Nov;27 Suppl 1:S167-S179. doi: 10.1016/S1166-7087(16)30707-2. Review. French.

PMID:
27846930
42.

[CCAFU french national guidelines 2016-2018 on testicular germ cell tumors].

Durand X, Fléchon A, Murez T, Rocher L, Camparo P, Morel-Journel N, Savoie PH, Ferretti L, Sèbe P, Méjean A.

Prog Urol. 2016 Nov;27 Suppl 1:S147-S165. doi: 10.1016/S1166-7087(16)30706-0. Review. French.

PMID:
27846929
43.

Toward solid-phase peptide fragment ligation by a traceless-Ugi multicomponent reaction approach.

Jobin S, Méjean A, Galindo SM, Liang X, Vézina-Dawod S, Biron E.

Org Biomol Chem. 2016 Nov 29;14(47):11230-11237.

44.

Cytoreductive Nephrectomy in the Tyrosine Kinase Inhibitor Era: A Question That May Never Be Answered.

Stewart GD, Aitchison M, Bex A, Larkin J, Lawless C, Méjean A, Nathan P, Oades G, Patard JJ, Paul J, Ravaud A, Escudier B; Renal Cross Channel Group.

Eur Urol. 2017 Jun;71(6):845-847. doi: 10.1016/j.eururo.2016.10.029. Epub 2016 Nov 1.

PMID:
27815086
45.

Comparison of 1800 Robotic and Open Partial Nephrectomies for Renal Tumors.

Peyronnet B, Seisen T, Oger E, Vaessen C, Grassano Y, Benoit T, Carrouget J, Pradère B, Khene Z, Giwerc A, Mathieu R, Beauval JB, Nouhaud FX, Bigot P, Doumerc N, Bernhard JC, Mejean A, Patard JJ, Shariat S, Roupret M, Bensalah K; French Comittee of Urologic Oncology (CCAFU).

Ann Surg Oncol. 2016 Dec;23(13):4277-4283. Epub 2016 Jul 13.

PMID:
27411552
46.

Localized chromophobe carcinomas treated by nephron-sparing surgery have excellent oncologic outcomes.

Bigot P, Bernhard JC, Flamand V, Gill I, Verhoest G, Beauval JB, Nouhaud FX, Suer E, Ploussard G, Hetet JF, Rigaud J, Baco E, Larré S, Sebe P, Koutlidis N, Descazeaud A, Eto M, Doerfler A, Roupret M, Vuong NS, Reix B, Matsugasumi T, Bakri AE, Albiges L, Soulié M, Patard JJ, Méjean A, Bensalah K; members of the Kidney Cancer group of the CCAFU.

Urol Oncol. 2017 Jan;35(1):35.e15-35.e19. doi: 10.1016/j.urolonc.2016.08.012. Epub 2016 Sep 28.

PMID:
27692834
47.

Fluorescence in situ hybridization of Microcystis strains producing microcystin using specific mRNA probes.

Zeller P, Méjean A, Biegala I, Contremoulins V, Ploux O.

Lett Appl Microbiol. 2016 Nov;63(5):376-383. doi: 10.1111/lam.12634. Epub 2016 Sep 14.

PMID:
27538762
48.

Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting.

Long JA, Bernhard JC, Bigot P, Lanchon C, Paparel P, Rioux-Leclercq N, Albiges L, Bodin T, Nouhaud FX, Boissier R, Gimel P, Méjean A, Masson-Lecomte A, Grenier N, Cornelis F, Grassano Y, Comat V, Le Clerc QC, Rigaud J, Salomon L, Descotes JL, Sengel C, Roupret M, Verhoest G, Ouzaid I, Arnoux V, Bensalah K; French association of Urology Cancerology Comitee (CCAFU).

World J Urol. 2017 Apr;35(4):649-656. doi: 10.1007/s00345-016-1913-4. Epub 2016 Aug 6.

PMID:
27498139
49.

[Cancer genetic screening for patient with multiple renal tumors: What is the current practice for what results?].

Beaugerie A, Verkarre V, Audenet F, Le Guilchet T, Hurel S, Richard S, Corréas JM, Fontaine E, Méjean A, Timsit MO.

Prog Urol. 2016 Jun;26(8):442-9. doi: 10.1016/j.purol.2016.06.001. Epub 2016 Jul 26. French.

PMID:
27473786
50.

Current practice and access to prostate MR imaging in France.

Renard-Penna R, Rouvière O, Puech P, Borgogno C, Abbas L, Roy C, Claudon M, Correas JM, Cormier L, Ploussard G, Mejean A, Tezenas-du-Montcel S, Rozet F.

Diagn Interv Imaging. 2016 Nov;97(11):1125-1129. doi: 10.1016/j.diii.2016.06.010. Epub 2016 Jul 20.

Supplemental Content

Loading ...
Support Center